News European regulators back Chiesi COPD triple therapy Chiesi takes on Seretide and other lung drugs with Trimbow.
News Shareholder’s exit from ‘frustrating’ GSK a blow for Walmsle... 'Continuity candidate' Emma Walmsley won't deliver the shake-up GSK needs, says Woodford
News GSK gets short term boost as second US Advair generic reject... FDA rejects Hikma drug, regulator has "major" issue with Mylan's rival.
News AZ failure cast further doubts over IL-13 drug asthma class AZ waits for second set of results due later this year.
News AZ hopes to boost respiratory pipeline with Pieris deal AstraZeneca is hoping to boost its respiratory pipeline in a deal potentially worth more than $2 billion with US biotech Pieris Pharmaceuticals.
News Neuralink unveils trial linking brain implant to robotic arm Neuralink has been given regulatory approval to start a new trial of its brain implant to see if it can be used to control a robotic arm
Digital Sponsored The AI effect in pharma commercial strategy: From data to re... Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights & actions from data. Click here for more.
